The Anti-Sm (Anti-Smith) antibody test is a specialized blood test used to detect autoimmune antibodies against proteins associated with Smith (Sm), which are components of the cell nucleus. This test is particularly important in diagnosing systemic lupus erythematosus (SLE), as the anti-Sm antibody is recognized as a highly specific marker for this disease and is positive in less than 10% of non-lupus patients. The presence of Anti-Sm in patients’ blood is often associated with disease activity and involvement of organs such as the kidneys (lupus nephritis) or the nervous system, although a direct correlation with disease severity has not always been proven.
This test is typically performed as part of the ENA (Extractable Nuclear Antigens) panel using methods such as ELISA (Enzyme-Linked Immunosorbent Assay) or Immunoblot. A positive Anti-Sm result, especially when combined with clinical symptoms like skin rash, arthritis, photosensitivity, and renal signs, strongly confirms a lupus diagnosis. However, the sensitivity of this test is low (approximately 20-30% in lupus patients), so a negative result does not rule out the disease. Interpretation of results should be done alongside supplementary tests such as ANA (Antinuclear Antibody), anti-dsDNA (anti-double-stranded DNA), and clinical evaluation.
Due to its high specificity, Anti-Sm is considered a key tool in the differential diagnosis of lupus from other autoimmune diseases and has been included in the international classification criteria for SLE.
